Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
SG
Susan Guthrie
Research Group Director, Science and Emerging Technology, RAND Europe
As patients, we often evaluate our interactions within the "system" of biomedical innovation with a simple question: "Did it work for me?" This evaluation considers many issues, including whether the best treatments are accessible and available, how they are delivered, and how they align with our identity, circumstances, and values to achieve the best possible health outcomes. However, of the myriad rankings that currently exist to measure health innovation, none can answer this fundamental question—which became even more pertinent as the COVID-19 pandemic underscored the longstanding health disparities in this country.
Recognizing this inadequacy, FasterCures, a center of the Milken Institute, spent the past two years conducting research, convening experts, and developing a comprehensive framework to evaluate whether the biomedical innovation ecosystem is working for patients and society. Ideally, policymakers and other stakeholders will use the framework to identify and fix misaligned incentives, systemic barriers and gaps, and inefficiencies—and then evaluate the impact of implemented changes. Ultimately, we hope this framework will help the biomedical innovation and care delivery ecosystem to work better for patients.
FasterCures, a center of the Milken Institute, has long supported policies that accelerate new, cutting-edge biomedical innovations to patients. The center was instrumental in gaining support for the 21st Century Cures Act in 2016, and...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
November 14, 2024 (Washington, DC) — The Milken Institute Science Philanthropy Accelerator for Research and Collaboration (SPARC), announced key resources and philanthropic capital to reshape scientific research fields and advance better...
Paul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.
Shepherding a drug from discovery to the market is a complex process that involves many actors. The process often begins with academic researchers making a breakthrough discovery in the lab and ends with pharmaceutical companies running...
The Milken Institute Center for Strategic Philanthropy and the Ann Theodore Foundation have released a new request for proposals (RFP) focused on understanding the underlying biology of sarcoidosis. Applications are open through January 20...
Washington, D.C. – January 13, 2022 – The Baszucki Brain Research Fund and the Milken Institute’s Center for Strategic Philanthropy are pleased to announce that 45 scientists worldwide will receive funding to advance research for bipolar...
Chad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events.
Each Venture Philanthropy transaction involves numerous complicated issues: governance, intellectual property ownership and licensing, termination, indemnification, and publication, among others, but the issue that encompasses the most...
Lung cancer, one of the most preventable diseases, surpasses all other cancer deaths worldwide. Of the 8.8 million people who died from some form of cancer in 2015, 1.69 million of them, or about 20 percent, succumbed to lung cancer...
Sarcoidosis is a complex, difficult-to-diagnose condition that can present in a variety of ways. It can disappear without symptoms in a couple of years for some people or lead to organ damage and death in others. Current treatment options...
FasterCures, a Center of the Milken Institute, and Society of Women’s Health Research (SWHR) advocated for the 21st Century Cures Act, which resulted in positive changes for women’s health research. The Cures Act, signed into law on...
Misophonia was named and described in the early 2000’s (Jastreboff and Jastreboff, 2001, 2002) and has since gained scientific recognition and clinical identification across a wide variety of disciplines (e.g., audiology, neuroscience...
BD 2 commits to finding answers for the 40 million individuals with bipolar disorder and those not yet diagnosed Washington, D.C. – September 12, 2022 – Today, three family philanthropies joined with the Milken Institute to commit $150...
Chad Clinton is the director of media relations for the Milken Institute. Hired to this role in August 2021, Clinton develops and executes strategies to amplify the Institute’s core messages by generating coverage of its pillar workstreams, experts, and events.
While some sounds can be annoying for most people, for a few, certain sounds like chewing, sniffling, or pen clicking can trigger an intense physical and emotional response. Those with this condition can experience increased heart rate...
